Letter to Orexo shareholders from CEO Nikolaj Sorensen

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo AB (publ) (STO:ORX) informs that the CEO of Orexo, Nikolaj Sorensen, today has sent a letter to all shareholders of the company. About Uroxatral (Alfuzosin) with free prescription The letter provides an update on the commercialization of Zubsolv® and the sales progress in the U.S. About Claritin (Loratadine) without Rx market as well as a general business update. Buy Imdur (Isosorbide) with free Rx The letter is also available on the company s home page at .orexo.com. About Orexo Orexo is a specialty pharmaceutical company commercializing its proprietary product Zubsolv® for treatment of opioid dependence in the US. Buy Estraderm without prescription Zubsolv is an advanced formulation of buprenorphine and naloxone using Orexo’s unique knowledge and expertise in sublingual drug delivery. Buy Oxytrol (Oxybutynin) with no Rx R&D is focusing on reformulation of known substances to new improved products that meet great unmet medical needs by using its patented proprietary technologies. Buy Body Wash online Orexo’s share is listed on Nasdaq Stockholm Exchange Mid Cap (STO: ORX) and is available as ADRs on OTCQX (ORXOY) in the US. http://web-md.blogspot.com Orexo’s global headquarters and R&D are based in Uppsala, Sweden. .orexo.com. For information about ZUBSOLV and opioid dependence, please visit .zubsolv.com and .outthemonster.com This information was brought to you by Cision news.cision.com